Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

PaperCitations, authors & open-access status

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 157 citations, 2020 year and closed oa status.

157
Citations
2020
Year
closed
OA Status

Related on ScholarIQ

Li‐Kai Tsai
Author
Amyloidosis: Diagnosis, Treatment, Outcomes
Topic
Amyloidosis: Diagnosis, Treatment, Outcomes
Topic
Skin and Cellular Biology Research
Topic
Alzheimer's disease research and treatments
Topic
470M+ articles · free account